The Indian wing of Johnson & Johnson, the multinational pharmaceutical company, has been found to have hidden key facts about its faulty hip implants form the national regulatory body. It also “suppressed” facts about their adverse health impact, reported The Indian Express.
The conglomerate did not inform the national regulator about the number of surgeries conducted, the harmful health impacts of the surgery and the number of such corrective surgeries performed on the patients, according to the Express report.
The information was put together by a Union Ministry of Health & Family Welfare report, submitted in February 2018. It further states that more than 3,600 patients with the faulty implants can’t be traced while at least four deaths have been confirmed.
Along with these, discrepancies were also found in data provided by J&J over a period of three years (2014-2017) to Central Drugs Standard Control Organization (CDSCO) of India. Of the 121 faulty cases reported by J&J, reports of only 48 are available with CDSCO.
The company further concealed the fact that the occurrence of the revision surgery was as high as 35 percent, as opposed to the 12 percent figure provided by them, reports Express.